© Copyright 2022– BOEHMERT & BOEHMERT
The rapid development in the biotechnology and pharmaceutical industry and the quickly changing laws relating to the field of life sciences are particularly challenging for the development of intellectual property protection.
Intellectual property rights have a significant influence on the value of a project, sometimes even that of a company.
Having a great deal of experience in the development of an effective patent strategy for pharmaceutical and biotechnology companies, we have developed strategies geared toward individual business models as well the prosecution and enforcement of patents and utility models. Our attorneys have sound knowledge of all major areas in biotechnology and pharmacy: molecular biochemistry, organic chemistry, immunology, galenics, plants, and personalised medicine and diagnostics.
Our attorneys are aware of the requirements investors and cooperation partners have regarding IP portfolios and other rights held by biotechnology and pharmaceutical companies. They are experienced in assisting with due diligence processes for asset/share deals and corporate transactions on both the buyer and seller side. We have many years of experience in the preparation of expert opinions with regard to a client’s own property rights as well as freedom-to-operate expert opinions.
We also assist our clients with projects, for example relating to the launching of products or the monitoring of competitors; we negotiate licencing agreements as well as research and development agreements.
Providing comprehensive assistance in the enforcement and defence of intellectual property rights in Germany and the coordination of multinational infringement proceedings, our attorneys routinely litigate patent disputes.
A law suit, filed by a Japanese company on the basis of a new patent, had to be adressed quickly.